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Abstract 
To determine the prevalence of metabolic syndrome (MetS) in Malaysian type 2 diabetic 
patients using WHO, NCEP ATP III, IDF and the new Harmonized definitions, and the 
concordance between these definitions. This study involved 313 patients diagnosed with type 
2 diabetes mellitus (T2DM) at two Malaysian tertiary hospitals. Socio-demographic data 
were assessed using a pre-tested interviewer-administered structured questionnaire. 
Anthropometric measurements were carried out according to standard protocols. Clinical and 
laboratory characteristics were examined. Kappa (k) statistics were used for the agreement 
between the four MetS definitions. The overall prevalence rates of MetS (95% CI) were 
95.8% (93.6-98.1), 96.1% (94.0-98.3), 84.8% (80.8-88.9) and 97.7% (96.1-99.4) according to 
the WHO, NCEP ATP III, IDF and the Harmonized definitions, respectively. The Kappa 
statistics demonstrated a slight to substantial agreement between the definitions (k = 0.179-
0.875, p < 0.001), where the WHO criteria revealed the highest concordance with the NCEP 
ATP III definition (k = 0.875, p < 0.001). The WHO against NCEP ATP III criteria evinced 
the highest sensitivity (99.66%) whereas Harmonized criteria against all the other three 
definitions showed the highest specificity (100%) in identifying MetS. In conclusion, the new 
Harmonized criteria established the highest prevalence of MetS among the four definitions 
applied. There was a very good concordance between the WHO and NCEP ATP III criteria. 
The extremely high prevalence of MetS observed in type 2 diabetic patients indicates an 
impending pandemic of CVD risk in Malaysia. Aggressive treatment of MetS components is 
required to reduce cardiovascular risk in T2DM.  
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